Atria Investments Inc Lowers Holdings in Relx Plc $RELX

Atria Investments Inc decreased its holdings in Relx Plc (NYSE:RELX) by 12.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,311 shares of the technology company’s stock after selling 8,999 shares during the quarter. Atria Investments Inc’s holdings in Relx were worth $3,440,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Bleakley Financial Group LLC grew its holdings in Relx by 1.5% in the 1st quarter. Bleakley Financial Group LLC now owns 14,147 shares of the technology company’s stock valued at $713,000 after buying an additional 207 shares during the period. Venturi Wealth Management LLC grew its holdings in Relx by 1.0% in the 2nd quarter. Venturi Wealth Management LLC now owns 24,476 shares of the technology company’s stock valued at $1,330,000 after buying an additional 232 shares during the period. Whipplewood Advisors LLC lifted its stake in shares of Relx by 15.7% in the 2nd quarter. Whipplewood Advisors LLC now owns 1,719 shares of the technology company’s stock valued at $93,000 after purchasing an additional 233 shares in the last quarter. Cynosure Group LLC lifted its stake in shares of Relx by 3.5% in the 1st quarter. Cynosure Group LLC now owns 6,951 shares of the technology company’s stock valued at $350,000 after purchasing an additional 236 shares in the last quarter. Finally, Bridgewater Advisors Inc. lifted its stake in shares of Relx by 2.1% in the 1st quarter. Bridgewater Advisors Inc. now owns 11,463 shares of the technology company’s stock valued at $617,000 after purchasing an additional 238 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on RELX shares. Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Barclays reaffirmed an “overweight” rating on shares of Relx in a research note on Tuesday, October 7th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Relx in a research note on Wednesday, October 8th. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Finally, Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy”.

Relx Stock Down 0.3%

Relx stock opened at $44.24 on Monday. The stock’s 50 day moving average price is $46.33 and its 200 day moving average price is $50.45. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. Relx Plc has a one year low of $43.88 and a one year high of $56.33.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.